Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.
Press releases published on April 14, 2025

Verano Announces Promotion and Appointment of Richard Tarapchak as Chief Financial Officer
Tarapchak brings more than 30 years of accounting and finance expertise to the role CHICAGO, April 14, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today …

Clene to Present at the Emerging Growth Conference
SALT LAKE CITY, April 14, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company dedicated to advancing therapies for …

SEALSQ Provides Integration Update: Wecan Token Expands Utility with Verified Identity from WISeID
Geneva, Switzerland, April 14, 2025 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today announced …

Red Cat Holdings Announces Closing of $30 Million Registered Direct Offering of Common Stock
SAN JUAN, Puerto Rico, April 14, 2025 (GLOBE NEWSWIRE) -- Red Cat Holdings, Inc. (Nasdaq: RCAT) (“Red Cat” or “Company”), a drone technology company integrating robotic hardware and software for military, government, and commercial operations, has …

AI-Media Unveils LEXI Voice at NAB Show 2025 - Global Reach with Live AI-Powered Voice Translation
BROOKLYN, N.Y. and NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- AI-Media (ASX: AIM), a global leader in AI-driven captioning and language technology, today announced the successful commercial launch of LEXI Voice at NAB Show 2025 in Las Vegas. The live …

Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing
RADNOR, Pa., April 14, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of its Non-Animal Navigator™ solution designed to help biopharmaceutical companies lead the …

AITX's RAD Builds Upon Urban Safety Momentum with Key Deployments in Major Cities
Cities Turn to RAD for Smarter, AI-Powered Public Safety Solutions Detroit, Michigan, April 14, 2025 (GLOBE NEWSWIRE) -- Artificial Intelligence Technology Solutions, Inc. (the “Company”) (OTCPK:AITX), a global leader in AI-driven security and productivity …

NeOnc Technologies Holdings, Inc. Expects Full Enrollment in Promising Phase 2a Trial of NEO100-01 for Malignant Gliomas in September
-- Trial Read-Out Data Expected in Early 2026 -- CALABASAS, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a clinical-stage biopharmaceutical company focused on innovative treatments for central nervous system …

Longevity Health Holdings Announces Execution of Merger Agreement With 20/20 Biolabs
PITTSBURGH, Pa. …

Impacful LLC Unveils Kairos IMS: Revolutionizing Health and Human Services Nonprofits
"Kairos IMS redefines the future for nonprofits, empowering them with cutting-edge tools to fuel social impact and transform community care like never before." FORT LAUDERDALE, FL, UNITED STATES, April 13, 2025 /EINPresswire.com/ -- On April 29th, …

InVivo Biosystems Advances AI Technology for Real Time Animal Health Monitoring
InVivo Biosystems announces acquisition of SBIR Phase II funding for AI-Powered Animal Health Monitoring Technology EUGENE, OR, UNITED STATES, April 13, 2025 /EINPresswire.com/ -- InVivo Biosystems, a leader in zebrafish research solutions, is proud to …

Enviri Corporation Announces Timing of First Quarter 2025 Results and Conference Call
PHILADELPHIA, April 14, 2025 (GLOBE NEWSWIRE) -- Enviri Corporation (NYSE: NVRI) today announced that it will issue its first quarter 2025 earnings results on Thursday, May 1, 2025 prior to NYSE market open. The Company will also host its quarterly …

Celularity Welcomes CMS Action on Medicare Local Coverage Determination for Skin Substitutes Products
FLORHAM PARK, N.J., April 14, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative and cellular medicine company, welcomes action by the Centers for Medicare …

NKGen Biotech To Present on the Use of Troculeucel for Alzheimer’s and Parkinson’s Disease at the 7th China International Biotechnology Conference & Exhibition
SANTA ANA, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer …

Inhibikase Therapeutics Announces Appointment of David McIntyre as Chief Financial Officer
BOSTON and ATLANTA, April 14, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company innovating small molecule kinase inhibitor therapeutics to treat pulmonary arterial …

FOREWARN to Provide Identity Verification Services to HiCentral MLS® to Promote Agent Safety
BOCA RATON, Fla., April 14, 2025 (GLOBE NEWSWIRE) -- FOREWARN, LLC, a red violet company (NASDAQ: RDVT) and the leading provider of real-time information solutions for real estate agents, today announced that HiCentral MLS® will offer FOREWARN® services to …

MKS Instruments Announces First Quarter 2025 Earnings Conference Call
ANDOVER, Mass., April 14, 2025 (GLOBE NEWSWIRE) -- MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that the Company will release first quarter 2025 financial results after market …

Fate Therapeutics Receives Regenerative Medicine Advanced Therapy (RMAT) Designation from FDA for FT819 to Treat Moderate to Severe Systemic Lupus Erythematosus (SLE)
– Recognizes potential of off-the-shelf CAR T-cell therapy to address significant unmet need and enables increased dialogue with FDA throughout the development process – RMAT review by FDA included initial clinical safety and activity data from ongoing …

Coherus Completes Strategic Transformation with Successful Divestiture of UDENYCA® Franchise
– $250 million post-close cash balance extends cash runway over two years into 2027, funding pipeline development through key data catalysts – – Coherus to focus exclusively on its innovative novel oncology programs including: – LOQTORZI®, a revenue- …

Certara Reports Preliminary First Quarter 2025 Financial Results; Announces $100 Million Share Repurchase Authorization
Reiterates Full-Year 2025 Guidance Arsenal Capital Partners agrees to a one-year lock-up RADNOR, Pa., April 14, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced expected revenue and …